Benefits and harms of perioperative high fraction inspired oxygen for surgical site infection prevention: a protocol for a systematic review and meta-analysis of individual patient data of randomised controlled trials

Author:

de Jonge Stijn WORCID,Hulskes Rick HORCID,Zokaei Nikoo Maedeh,Weenink Robert P,Meyhoff Christian S,Leslie Kate,Myles PaulORCID,Forbes Andrew,Greif Robert,Akca OzanORCID,Kurz Andrea,Sessler Daniel I,Martin Janet,Dijkgraaf Marcel GWORCID,Pryor KaneORCID,Belda F Javier,Ferrando Carlos,Gurman Gabriel M,Scifres Christina M,McKenna David S,Chan Matthew TV,Thibon Pascal,Mellin-Olsen Jannicke,Allegranzi Benedetta,Boermeester Marja,Hollmann Markus W

Abstract

IntroductionThe use of high fraction of inspired oxygen (FiO2) intraoperatively for the prevention of surgical site infection (SSI) remains controversial. Promising results of early randomised controlled trials (RCT) have been replicated with varying success and subsequent meta-analysis are equivocal. Recent advancements in perioperative care, including the increased use of laparoscopic surgery and pneumoperitoneum and shifts in fluid and temperature management, can affect peripheral oxygen delivery and may explain the inconsistency in reproducibility. However, the published data provides insufficient detail on the participant level to test these hypotheses. The purpose of this individual participant data meta-analysis is to assess the described benefits and harms of intraoperative high FiO2compared with regular (0.21–0.40) FiO2and its potential effect modifiers.Methods and analysisTwo reviewers will search medical databases and online trial registries, including MEDLINE, Embase, CENTRAL, CINAHL, ClinicalTrials.gov and WHO regional databases, for randomised and quasi-RCT comparing the effect of intraoperative high FiO2(0.60–1.00) to regular FiO2(0.21–0.40) on SSI within 90 days after surgery in adult patients. Secondary outcome will be all-cause mortality within the longest available follow-up. Investigators of the identified trials will be invited to collaborate. Data will be analysed with the one-step approach using the generalised linear mixed model framework and the statistical model appropriate for the type of outcome being analysed (logistic and cox regression, respectively), with a random treatment effect term to account for the clustering of patients within studies. The bias will be assessed using the Cochrane risk-of-bias tool for randomised trials V.2 and the certainty of evidence using Grading of Recommendations, Assessment, Development and Evaluation methodology. Prespecified subgroup analyses include use of mechanical ventilation, nitrous oxide, preoperative antibiotic prophylaxis, temperature (<35°C), fluid supplementation (<15 mL/kg/hour) and procedure duration (>2.5 hour).Ethics and disseminationEthics approval is not required. Investigators will deidentify individual participant data before it is shared. The results will be submitted to a peer-review journal.PROSPERO registration numberCRD42018090261.

Funder

Amsterdams Universiteitsfonds

Publisher

BMJ

Subject

General Medicine

Reference66 articles.

1. Multistate Point-Prevalence Survey of Health Care–Associated Infections

2. Surgical site infection: Incidence and impact on hospital utilization and treatment costs

3. Control ECfDPa . Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC, 2013.

4. ECDC . Surveillance of surgical site infections in Europe 2010–2011. Stockholm: ECDC, 2013.

5. Surgical site infection - a European perspective of incidence and economic burden

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3